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Simple Summary: The German cockroach Blattella germanica is a good model to study complex
symbiotic relationships because the following two symbiotic systems coexist in a single individual:
the endosymbiont Blattabacterium (living inside specialized cells called bacteriocytes) and the gut
microbiota. Although the role of the endosymbiont has been fully elucidated, the function of the
gut microbiota remains unclear. The study of the gut microbiota will benefit from the availability
of insects deprived of Blattabacterium. Our goal is to determine the effect of the removal (or, at
least, the reduction) of the endosymbiont population on the cockroach’s fitness, in a normal gut
microbiota community. For this purpose, we treated our cockroach population with rifampicin to
decrease the amount of endosymbiont in the following generation. As the treatment also affects
rifampicin-sensitive gut bacteria, we allowed it to recover for at least 20 days before sampling. We
found that after this antibiotic treatment, the endosymbiont population remained extremely reduced
and only the microbiota were able to recover, although it could not compensate for the endosymbiont
role, and the host’s fitness was drastically affected. This accomplished reduction, however, is not
homogenous and requires further study to develop stable quasi-aposymbiotic cockroaches.
Abstract: Blattella germanica presents a very complex symbiotic system, involving the following two
kinds of symbionts: the endosymbiont Blattabacterium and the gut microbiota. Although the role of
the endosymbiont has been fully elucidated, the function of the gut microbiota remains unclear. The
study of the gut microbiota will benefit from the availability of insects deprived of Blattabacterium.
Our goal is to determine the effect of the removal (or, at least, the reduction) of the endosymbiont
population on the cockroach’s fitness, in a normal gut microbiota community. For this purpose, we
treated our cockroach population, over several generations, with rifampicin, an antibiotic that only
affects the endosymbiont during its extracellular phase, and decreases its amount in the following
generation. As rifampicin also affects gut bacteria that are sensitive to this antibiotic, the treatment
was performed during the first 12 days of the adult stage, which is the period when the endosymbiont
infects the oocytes and lacks bacteriocyte protection. We found that after this antibiotic treatment, the
endosymbiont population remained extremely reduced and only the microbiota was able to recover,
although it could not compensate for the endosymbiont role, and the host’s fitness was drastically
affected. This accomplished reduction, however, is not homogenous and requires further study to
develop stable quasi-aposymbiotic cockroaches.
Keywords: Blattella germanica; symbiosis; Blattabacterium; gut microbiota; rifampicin; aposymbiont
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1. Introduction
The cockroach Blattella germanica (Blattodea) is a good model to study complex sym-
biotic relationships because the following two symbiotic systems coexist in a single indi-
vidual: the obligate endosymbiont Blattabacterium, a flavobacterium responsible for the
synthesis of essential amino acids and the recycling of the host nitrogen reservoir [1], and
very rich gut microbiota. Termites also belong to the order Blattodea. Blattabacterium
is present in all cockroaches and the basal termite Mastotermes darwiniensis, indicating
that the infection with the ancestral flavobacterium that gave rise to the endosymbiont
occurred in the ancestor of termites and cockroaches. However, throughout evolution,
and associated with a change to feeding on wood, the endosymbiont was lost in the rest
of the termite lineages, being replaced by a specialized microbiota that, in addition to
the endosymbiont functions, participated in lignocellulose degradation [2]. On the other
hand, studies performed on insects that rely on obligate mutualistic endosymbionts to
complement their nutrient-poor diets indicate that their microbial symbionts are composed
of a few primary (obligate) and secondary (facultative) symbionts, mostly located in the
insect body cavities, inside specialized cells called bacteriocytes, inside the gut epithelial
cells or crypts (sac-like structures), but lack complex extracellular gut microbiota [3]. Thus,
the reason why Blattella needs intestinal microbiota in addition to Blattabacterium remains
unknown. Both symbiotic systems are located in different host compartments, the fat body
and the hindgut, which impedes their direct crosstalk. Therefore, their communication or
metabolic complementation, if existent, must be performed through the host.
The first 16S rRNA gene study on the bacterial gut microbiota of B. germanica through
development [4] demonstrated that only Blattabacterium is present in the ootheca, confirm-
ing the absence of vertical transmission of the gut microbiota. The new-born nymphs are
germ-free, and the bacterial load increases from nymphal instar one to two, and stays
constant until the adult stage.
Later on, we tested the effect of different antibiotics (rifampicin [5], vancomycin and
ampicillin [6], and kanamycin [7]) on the gut microbiota. In all four cases, a strong effect
was observed on the treated generation, in terms of composition, diversity, and network
complexity; however, only rifampicin reduced the Blattabacterium population [5], and its
effect on the endosymbiont was observed in the following generation. This delayed action
is explained by the biology of the endosymbiont, as it appears extracellularly in the ovaries
at the adult stage until the infection of the mature oocytes, when the adult is 7–10 days
old [8].
Aposymbiotic organisms, deprived of their endosymbiont, but in which the gut micro-
biota are not affected, would be useful to study the role of the gut microbiota and if they can
complement (or substitute) Blattabacterium. Several approaches to produce aposymbiotic
cockroaches (high temperature, or treatment with lysozyme and several antibiotics, which
could be injected into the haemolymph or added in the food) were already tested in the mid-
dle of the 20th century, by the pioneers of the symbiosis studies [9,10]. These early works
already recognized, by means of biochemical, physiological and microscopic techniques,
that the presence of the endosymbiont is critical to the host’s fitness and reproduction. For
this reason, we focused this study on obtaining quasi-aposymbiotic cockroaches (i.e., with
the lowest possible endosymbiont load) using an antibiotic treatment, without disturbing
the gut microbiota. We analysed the effects of the endosymbiont reduction on the other
two symbiotic partners (host and gut microbiota), by analysing changes in the host’s fit-
ness (developmental time, reproductive capability, and viability) and the gut microbiota
composition.
2. Materials and Methods
2.1. Blattella germanica Rearing Conditions
A population of B. germanica originating from a laboratory population housed by Dr.
X. Bellés’ group at the Institute of Evolutionary Biology (CSIC-UPF, Barcelona, Spain) was
reared in plastic jars with aeration inside climatic chambers at the Institute for Integrative
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Systems Biology (University of Valencia—CSIC) at 25 ◦C, 60% humidity and photoperiod
of 12 h light/12 h darkness. Insects were fed dog-food pellets (Teklad global 21% protein
dog diet 2021C, Envigo, Madison, WI, USA) and water ad libitum. Rifampicin (0.1 mg/mL)
(Alfa Aesar, Kandel, Germany) was supplied in the water when needed.
2.2. Experimental Design
Figure 1 presents a scheme of the experimental design and a summary of all sam-
ples analysed. The experiment is designed to span several generations to reduce the
endosymbiont population progressively (Figure 1a). Between 0 and 48 h after ecdysis,
adult cockroaches were collected to start a sex-balanced synchronized population. This
first generation (G1) was distributed into the following two subpopulations: one was not
treated with the antibiotic and served as a control (C), and the other (R) was treated with
rifampicin 0.1 mg/mL for 12 days. At the second generation (G2), within 48 h of hatching,
nymphs of the antibiotic-treated population were used to start two new subpopulations,
which were antibiotic-treated (RR) or not (RC) at the adult stage. In the third generation
(G3), the same treatment as the corresponding G2 was applied, leading to populations RRR
and RCC.
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Figure 1. Experimental design to obtain B. germanica quasi-aposymbionts without affecting the gut microbiota. (a) Original
design. The antibiotic rifampicin is supplied to a synchronized adult population of B. germanica in three successive
generations. At G1, the following two populations are established: a control one without antibiotic (C) and another
one treated with rifampicin for the first 12 days of the adult stage (R). At G2, within 48 h of hatching, nymphs of the
antibiotic-treated population are used to start two new populations, with and without antibiotic treatment in the adult
stage (RR and RC, spectively). At G3, the antibiotic is su plied again to the treated population only (RRR) in t e adult
stage, while the sister populatio remains untreated (RCC) to allow complete r covery. (b) Modified design. Because the
nymphs that hatched after the first rifampicin treatment present two developmental phenotypes (slow and fast), only those
with a delay in their developmental time were used for the rifampicin treatment over three generations, and to analyse
their recovery after ceasing the antibiotic treatment for two generations. Adult females were taken for dissection after the
hatching of nymphs in G2 and G3.
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During G2, some individuals developed normally, while others were delayed. For
this reason, on day 20 the insects were separated based on this “developmental speed” in
two groups, fast (Rf) and slow (Rs) (Figure 1b). When becoming adults, subpopulation Rf
was maintained without treatment (RfC), while Rs was split into two halves, untreated
(RsC) and antibiotic-treated (RsR). For the latter, an individualized system was designed in
which each female reaching the adult stage was put in a container with a male, and the
antibiotic was supplied for 12 days, after which all individuals with the same treatment
were put together. The nymphs that hatched in G3 in each slow population were raised
to adults, and were treated or not in the same conditions as their parents, giving rise to
the populations RsRR, to continue with the treatment, and RsCC to check the recovery of
the endosymbiont. A single untreated population was maintained for the fast population
(RfCC).
2.3. Cockroach Dissections
At selected time points (Figure 1b), adult females were dissected after hatching their
nymphs (i.e., after the oothecae were fully mature) to collect their hindguts and fat bodies.
Only females were dissected to reduce statistical noise produced by sex bias. Cockroaches
were anesthetized using a CO2 stream and dissected under stereomicroscope. The hindgut
was isolated, opened and cleaned in Krebs–Ringer bicarbonate buffer (Sigma-Aldrich, St.
Louis, MI, USA) to remove faeces. The fat body was recovered in Krebs–Ringer buffer.
Samples were frozen in liquid nitrogen and stored at −80 ◦C until used.
2.4. Fitness Parameters Determination
The following several fitness parameters were measured through the insect’s life-
cycle: development (number of days from hatching to reach adult stage and to the ootheca
hatching), reproductive capability (number of nymphs per ootheca), and viability (%
nymphs’ survival in G2). Statistical differences were analysed with ANOVA and t-test,
when appropriate.
2.5. DNA Extraction and Quantitative PCR
Fat body and hindgut total DNA were extracted following the protocols previously
described [6]. Fat body DNA was resuspended in 50 µL of Milli-Q water, quantified with
a Qubit 3.0 fluorimeter (Thermo Fisher Scientific, USA), and diluted up to 0.05 ng/µL.
Endosymbiont population was analysed by qPCR on fat body samples using AriaMx
real-time PCR system (Agilent Technologies, Germany). The genes ureC (accession number:
NC_013454.1) and actin5C (accession number: AJ861721.1) were used as specific endosym-
biont and host, respectively, using primers previously described (ureC quantification: UC1F,
5′-GTCCAGCAACTGGAACTATAGCCA-3′; UC1R, 5′-CCTCCTGCACCTGCTTCTATTTGT-
3′. actin5C quantification: ActinF, 5′-CACATACAACTCCATTATGAAGTGCGA-3′; ActinR,
5′-TGTCGGCAATTCCGGTACATG-3′) [6], and the relative ratio ureC/actin5C was ob-
tained. ANOVA and t-test were applied to analyse statistical differences.
2.6. DNA Sequencing and Bioinformatics Analyses
The V3–V4 region of the 16S rRNA gene was amplified by PCR from hindgut DNA with
16SrRNA Illumina sequencing standard primers (forward primer: 5′-CCTACGGGNGG
CWGCAG-3′; reverse primer: 5′-GACTACHVGGGTATCTAATCC-3′), as described in [11],
and sequenced with Illumina MiSeq at the Sequencing and Bioinformatic Service facilities
of FISABIO. The obtained reads have been submitted to the European Nucleotide Archive
(ENA), and the assigned study accession number is PRJEB47828 (ERS7664059-ERS7664084).
DNA reads were analysed using the QIIME2 platform [12], version qiime2-2019.7.
After data demultiplexing, reads were denoised with DADA2 [13]. Taxonomic classification
was performed using the SILVA 132 database [14]. Statistical analyses were performed
using GNEISS and diversity plugins in QIIME2 and R packages.
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Several biodiversity indexes have been calculated using plugins implemented in the
QIIME2 pipeline [12]. Shannon index measures the bacterial distribution within each
sample (alpha diversity). As for the analysis of beta diversity, Aitchison distance describes
the dissimilarity between samples for compositional data [15,16], while weighted UniFrac
takes into consideration the evolutionary relationship among the amplicon sequence
variants (ASV) identified in each sample [17]. A principal coordinate analysis (PCoA)
plot shows, in the axes, the parameters that best explain the distances between these
bacterial communities.
3. Results and Discussion
In our previous work, we determined the putative functions of the gut microbiota,
following a metagenomic approach [6,7]. However, the impact that those bacterial functions
have on the host, and if they can somehow replace the endosymbiont’s essential functions,
have not been proven. To empirically determine such effects, the use of hosts with a null
or reduced load of Blattabacterium will be highly informative. Furthermore, they will also
show how essential the endosymbiont is in the host’s development and fitness. Among the
antibiotics previously tested in our group, to disturb the gut microbiota in B. germanica, only
rifampicin can also affect Blattabacterium; its effect is observed in the following generation,
as a reduction in the amount of endosymbiont in the offspring. It has been proposed that
the antibiotic only affects the endosymbiont in the ovaries when it leaves the protection
of the bacteriocytes to infect the oocytes, but not inside the bacteriocytes, except if high
doses of antibiotic are used [18]. In the present experiment, rifampicin was supplied at
half the concentration used in the previous work [5], and only for the first 12 days of the
adult stage, with the aim of reaching the endosymbiont prior the oocytes’ invasion, while
affecting the cockroaches’ fitness and gut microbiota as little as possible. It was designed
this way because the antibiotic treatment also affects the gut community and could reduce
insect viability, and the treatment must be maintained during several generations, in order
to progressively reduce the endosymbiont load. In fact, the microbiota’s recovery is mainly
expected by coprophagia once the antibiotic is removed [5–7], for which we expect there
to be enough time because the females are dissected at least 20 days after the end of the
treatment, i.e., the time necessary for the ootheca to hatch.
The results of Blattabacterium quantification were striking (Figure 2a). The treatment
for 12 days in G1 was able to reduce the endosymbiont population in some G2 individuals,
suggesting that the antibiotic was affecting the endosymbiont during the infection of
the ovaries, as expected [5]. However, this effect was not homogeneous, as we found
two insect groups in G2, with different developmental times (fast and slow) (Figure 1b).
Furthermore, the endosymbiont population was not equally reduced among the offspring
of the treated cockroaches, and reduced amounts correlate with a slow development
(less than 0.1 ureC/actin ratio in fat body DNA from the treated samples of the slow
population, compared to 103 in the control samples; Table 1). When the affected G2 was not
treated again with rifampicin (RsC), the corresponding G3 population RsCC had normal
Blattabacterium amounts. Surprisingly, we also observed that a G2 with a strong reduction
in the endosymbiont population (RsR), treated again (RsRR), gave rise to a normal G3. This
full recovery, even when the antibiotic was supplied in every generation, implies that the
treatment window in G2 was not enough to have an effect on G3. Thus, it appears that the
few individuals that reached the next generation were those that escaped the treatment.
These results justify the need to keep a constant antibiotic stress, because in each ovary’s
infection process, the endosymbiont population can grow again.
The differences in host development observed at G2 in our experiment can have
several causes. First of all, despite starting with a synchronized population between 0
and 48 h after ecdysis, different adult individuals have a different time of development,
following a normal distribution. Secondly, it must be taken into account that the G2
individuals born on 15 April did not come from a single ootheca, but from a collection
of oothecae that hatched in the same 48 h. As the rifampicin is provided with water, it is
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possible that the treatment was not equally effective in different G1 females, and, therefore,
their offspring would be differently affected regarding the Blattabacterium load. This wide
variability in the samples had already been observed since the pioneering studies, in the
second half of the 20th century, to obtain aposymbiotic cockroaches, where it was observed
that in nymphs from the same ootheca, the amount of endosymbiont was not always
equally affected by the antibiotic treatments [18].
Table 1. Female cockroaches of G2 and G3 analysed in this study. Columns indicate the dates (day/month/year) corre-
sponding to relevant points in the developmental process (hatching, adult ecdysis, ootheca appearance, offspring hatching),
number of days from hatching to reach adult stage and to next-generation hatching, reproductive capability (nymphs per

















RsR-1 a 15/04/18 25/06/18 10/07/18 06/08/18 71 113 31 0.0932
RsR-2 15/04/18 26/06/18 _ _ 72 _ _ 0.0001
RsR-3 15/04/18 28/06/18 _ _ 74 _ _ 0.0723
RsR-4 15/04/18 03/07/18 _ _ 79 _ _ 0.1797
RsR-5 15/04/18 20/07/18 _ _ 96 _ _ nd
RsC-1 b 15/04/18 13/06/18 26/07/18 13/09/18 59 151 24 6868.99
RsC-2 15/04/18 09/07/18 _ _ 85 _ _ 16.802
RfC-1 c 15/04/18 06/06/18 19/06/18 20/07/18 52 96 13 1470.02
RfC-2 15/04/18 09/06/18 21/06/18 26/07/18 55 102 16 1103.08
RfC-3 15/04/18 10/06/18 20/07/18 03/08/18 56 110 6 1015.49
RfC-4 15/04/18 14/06/18 20/07/18 10/08/18 60 117 33 514.67
RfC-5 15/04/18 18/06/18 20/07/18 16/08/18 64 123 33 nd
RsRR-1 06/08/18 10/10/18 22/10/18 27/11/18 65 113 39 2223.70
RsRR-2 06/08/18 22/10/18 16/11/18 11/12/18 77 127 19 1465.86
RsRR-3 06/08/18 29/10/18 16/11/18 14/12/18 84 130 28 735.42
RsRR-4 06/08/18 05/11/18 27/11/18 26/12/18 91 142 22 5872.96
RsRR-5 06/08/18 09/11/18 27/11/18 26/12/18 95 142 20 nd
RsCC-1 13/09/18 30/10/18 20/11/18 26/12/18 47 104 36 16.42
RsCC-2 13/09/18 03/11/18 27/11/18 26/12/18 51 104 30 2263.17
RsCC-3 13/09/18 06/11/18 26/12/18 03/01/19 54 112 30 2033.46
RsCC-4 13/09/18 20/11/18 26/12/18 03/01/19 68 112 22 520.99
RsCC-5 13/09/18 20/11/18 26/12/18 08/01/19 68 117 40 nd
RfCC-1 20/07/18 10/09/18 14/09/18 23/10/18 52 95 44 5106.13
RfCC-2 20/07/18 11/09/18 17/10/18 24/10/18 53 96 45 463.96
RfCC-3 20/07/18 12/09/18 17/10/18 26/10/18 54 98 46 1017.05
RfCC-4 20/07/18 13/09/18 17/10/18 26/10/18 55 98 44 504.08
RfCC-5 20/07/18 13/09/18 17/10/18 29/10/18 55 101 46 nd
a All RsRR samples come from the RsR-1 offspring; b all RsCC samples come from the RsC-1 offspring; c all RfCC samples come from the
RfC-1 offspring; a hyphen indicates that the corresponding female did not produce an oothecae; nd: non-determined. Each dark-coloured
line on the second generation corresponds to the ootheca that served to start the next generation with the same colour.
We checked if the reduction in Blattabacterium affects the nymphs’ viability and insects’
reproductive capability. During G1, we found no differences between the treated and
control populations in any of the fitness parameters analysed (data not shown), as expected,
because (as above stated) Blattabacterium is not affected during its intracellular stage in
the fat body, but only during the infection of the ovaries and oocytes, and the treatment
was applied in the adult stage. However, at G2, we observed a high mortality rate in
nymphs from females treated with rifampicin (up to 90% mortality before becoming
adults, while the control population had a mortality rate of 13.8%, SD 7.1). The reduction
in the endosymbiont population was also accompanied by an extension of the host’s
developmental time (up to 96 days to reach adult stage, instead of 50–70 days in normal
conditions; Figure 1b, Table 1). Our hypothesis is that the endosymbiont reduction increases
the developmental time, expanding the time window of the ovaries’ infection, which
reduces the effectiveness of the treatment in the following generation with the same
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treatment regimen. The effects of supplying rifampicin for two or three consecutive
generations clearly link the antibiotic treatment to a significant reduction in reproductive
capacity, since the oothecae production and the number of nymphs per oothecae were
affected in all the experimental groups treated, at least once, with the antibiotic (Figure 3).
This decrease in reproductive fitness, however, cannot be attributed to the endosymbiont
reduction, as it is detected in all the treated populations in G2 and G3, even with a normal
amount of endosymbiont.




    (a)                    (b) 
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all the samples as a global p-value is shown in top left, and t-test values comparing each experimental sample to the control 
are shown above the bars (ns, p > 0.05; ****, p < = 0.0001). (b) PCoA analysis of the gut microbiota based on weighted 
UniFrac distances classified by sample type, indicating, on the axes, the percentages of variation explained by the principal 
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We checked if the reduction in Blattabacterium affects the nymphs’ viability and in-
sects’ reproductive capability. During G1, we found no differences between the treated 
and control populations in any of the fitness parameters analysed (data not shown), as 
expected, because (as above stated) Blattabacterium is not affected during its intracellular 
stage in the fat body, but only during the infection of the ovaries and oocytes, and the 
treatment was applied in the adult stage. However, at G2, we observed a high mortality 
rate in nymphs from females treated with rifampicin (up to 90% mortality before becom-
ing adults, while the control population had a mortality rate of 13.8%, SD 7.1). The reduc-
tion in the endosymbiont population was also accompanied by an extension of the host’s 
developmental time (up to 96 days to reach adult stage, instead of 50–70 days in normal 
conditions; Figure 1b, Table 1). Our hypothesis is that the endosymbiont reduction in-
creases the developmental time, expanding the time window of the ovaries’ infection, 
which reduces the effectiveness of the treatment in the following generation with the same 
treatment regimen. The effects of supplying rifampicin for two or three consecutive gen-
erations clearly link the antibiotic treatment to a significant reduction in reproductive ca-
pacity, since the oothecae production and the number of nymphs per oothecae were af-
fected in all the experimental groups treated, at least once, with the antibiotic (Figure 3). 
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reduction, as it is detected in all the treated populations in G2 and G3, even with a normal 
amount of endosymbiont. 
We also studied the gut microbiota composition in all the samples in the experiment. 
A total of 2,599,001 reads were analysed, 78.03% of which passed the quality test. The 
taxonomic distribution was analysed at the phylum level (Figure 4). The most abundant 
phyla in all the samples correspond to Bacteroidota, Firmicutes, Desulfobacterota (previ-
ously included in the phylum Proteobacteria [19]), Proteobacteria, Fusobacteriota, and 
Planctomycetota, as previously reported [7]. A strong reduction in Fusobacteria was ob-
served in most treated samples in G2 and G3, and it was the only bacterial genus that was 
not recovered when no antibiotic was added in the following generations (unnoticeable 
amounts in all the samples from population RsCC, and three out of four samples of pop-
ulation RfCC). This reduction does not correlate with the amount of Blattabacterium, 
which was normal in those samples. No significant effects on the host’s reproductive ca-
pability were noticed in these populations either. These findings are in consonance with 
Figure 2. Effects of the rifampicin treatment on the two symbiotic systems of B. germanica. (a) Relative quantification of the
endosymbiont in the fat body. Ratio ureC/actin5C in each sample of the analysed populations. ANOVA test comparing all
the samples as a global p-value is shown in top left, and t-test values comparing each experimental sample to the control
are shown above the bars (ns, p > 0.05; ****, p < = 0.0001). (b) PCoA analysis of the gut microbiota based on weighted
UniFrac distances classified by sample type, indicating, on the axes, the percentages of variation explained by the principal
coordinates.
We also studied the gut microbiota composition in all the samples in the experiment.
A total of 2,599,001 reads were analysed, 78.03% of which passed the quality test. The taxo-
nomic distribution was analysed at the phylum level (Figure 4). The most abundant phyla
in all the samples correspond to Bacteroidota, Firmicutes, Desulfobacterota (previously
included in the phylum Proteobacteria [19]), Proteobacteria, Fusobacteriota, and Plancto-
mycetota, as previously reported [7]. A strong reduction in Fusobacteria was observed in
most treated samples in G2 and G3, and it was the only bacterial genus that was not recov-
ered when no antibiotic was added in the following gener tions (unnoticeable amounts in
all the samples fro p pulation RsCC, and three out of four samples of population RfCC).
This reduction does not correlate with the amount of Blattabacterium, which wa normal in
those samples. No significant effects on the host’s reproductive capa lity were noticed
in these populations either. Th se findings are in consonance with pre ious results [5]
ere, in rifampicin-treat d samples, a significant increase in Fusobacteria as found in
G1, but was followed by a strong reductio during G2. Such changes could b explain d
by a dependence on the presence/absence of c mpetitors during hindgut colonization [20].
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m i i t r
e, b i t , t
t a reco ers after antibiotic exposure [5–7]. All those st dies used longer tr atment
periods, even during full enerations. Thus, t e lack of such strong effects observed here
could be explained by the reduced treatment window a the long time given for recovery
(at least 20 days after the treatment) before the sampling points. This indicates that this is a
good strategy to reach our goal of affecting the endosymbiont, without a drastic effect in
the gut microbiota.
Biology 2021, 10, 1013 9 of 11
There were differences between the gut microbiota of all the experimental groups and
the control population, as revealed by the Aitchison distance analysis (Figure 5), but they
cannot be explained either by the antibiotic treatment or the amount of Blattabacterium.
These results are reinforced by the analysis of the taxonomic distribution (weighted UniFrac
PCoA; Figure 2b) and the alpha diversity (Shannon index; Figure 6), where the only
significant differences were detected in the RsCC population.
A PERMANOVA test was applied to the Aitchison distance results by comparing each
sample against all the others. The analysis revealed significant differences (p-value < 0.05)
in all the comparisons with the control and RsCC populations (except for the RsC popula-
tion, probably due to the small sample size). The corresponding Aitchison distances are
presented in Figure 5. However, the weighted UniFrac PCoA (Figure 2b) shows only a
slight separation of the control and RsCC population from the others. These results could
indicate that, even though the re-established gut microbiota, after the rifampicin treatment
in G1, is not exactly the same as in the control population, the taxonomical groups involved
are quite similar and might be performing similar functions. Even though the case of
the RsCC population is surprising, the changes in the microbiota composition are not
associated with retardation in development, while the amounts of endosymbiont were
normal in this population and, therefore, would not be useful to study a putative role of
the gut microbiota to replace the endosymbiont. In addition, no interaction between the
gut microbiota and the endosymbiont was detected, as there were no significant changes in
G2 in the gut communities of the quasi-aposymbiotic populations, compared with those
with a normal Blattabacterium load.
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4. Conclusions 
The selected treatment regimen (0.1 mg/mL of rifampicin for the first 12 days of the 
adult stage) has been successful in reducing the endosymbiont population of B. germanica, 
while affecting the gut microbiota as little as possible. However, its effect was not homo-
geneous among the cockroach population. Moreover, after one generation with reduced 
amounts of Blattabacterium, the offspring of the next generation recover completely, even 
though the antibiotic is supplied following the same schedule, probably because the ex-
tracellular stage of Blattabacterium has been delayed due to the developmental retard. 
The negative effects on viability and reproductive fitness detected in rifampicin-
treated populations are not related to changes in the gut microbiota, and cannot be at-
tributed exclusively to the endosymbiont reduction, or to the rifampicin treatment itself. 
Moreover, apparently normal gut microbiota, recovered after cessation of the antibiotic 
treatment, are not able to replace the functions of Blattabacterium. 
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4. Conclusions
The selected treatment regimen (0.1 mg/mL of rifampicin for the first 12 days of
the adult stage) has been successful in reducing the endosymbiont population of B. ger-
manica, while affecting the gut microbiota as little as possible. However, its effect was
not homogeneous among the cockroach population. Moreover, after one generation with
reduced amounts of Blattabacterium, the offspring of the next generation recover completely,
even though the antibiotic is supplied following the same schedule, probably because the
extracellular stage of Blattabacterium has been delayed due to the developmental retard.
The negative effects on viability and reproductive fitness detected in rifampicin-treated
populations are not related to changes in the gut microbiota, and cannot be attributed
exclusively to the endosymbiont reduction, or to the rifampicin treatment itself. Moreover,
apparently normal gut microbiota, recovered after cessation of the antibiotic treatment, are
not able to replace the functions of Blattabacterium.
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